EUVIMEDEUVIMED entdecken
Crossref

Kv1.5 Inhibition in Atrial Fibrillation: Molecular Mechanisms, Translational Challenges, and Implications for Equitable Rhythm Control

M. Molitor Frankie, M. Olowofeso Abisola, A. Afolabi Oluwaseun, S. Zinkevich Natalya

Cardiovascular Science · 2026 · 3 (2) · 10007-10007

DOI: 10.70322/cvs.2026.10007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Science, 2026. Verfasst von M. Molitor Frankie und 3 weiteren Autor:innen. Die Arbeit nennt 139 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Frankie, M. M., Abisola, M. O., Oluwaseun, A. A., & Natalya, S. Z. (2026). Kv1.5 Inhibition in Atrial Fibrillation: Molecular Mechanisms, Translational Challenges, and Implications for Equitable Rhythm Control. Cardiovascular Science, 3(2), 10007-10007. https://doi.org/10.70322/cvs.2026.10007

Vancouver

Frankie MM, Abisola MO, Oluwaseun AA, Natalya SZ. Kv1.5 Inhibition in Atrial Fibrillation: Molecular Mechanisms, Translational Challenges, and Implications for Equitable Rhythm Control. Cardiovascular Science. 2026;3(2):10007-10007. doi:10.70322/cvs.2026.10007

BibTeX
@article{Frankie2026,
  author = {Frankie, M. Molitor and Abisola, M. Olowofeso and Oluwaseun, A. Afolabi and Natalya, S. Zinkevich},
  title = {Kv1.5 Inhibition in Atrial Fibrillation: Molecular Mechanisms, Translational Challenges, and Implications for Equitable Rhythm Control},
  journal = {Cardiovascular Science},
  year = {2026},
  volume = {3},
  number = {2},
  pages = {10007--10007},
  doi = {10.70322/cvs.2026.10007}
}
Kostenlos starten →